Source: Eur Respir J, 55 (4) 2000326; 10.1183/13993003.00326-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Liza Botros, Anton Vonk Noordegraaf, Jurjan Aman. Vanishing vessels aboding pulmonary disease: a role for VEGFR2. Eur Respir J, 55 (4) 2000326; 10.1183/13993003.00326-2020

Member's Comments

No comment yet.

Related content which might interest you: Possible role of imatinib in clinical pulmonary veno-occlusive disease Source: Eur Respir J 2008; 32: 232-235 Year: 2008 Pulmonary hypertension: the science behind the disease spectrum Source: Eur Respir Rev 2012; 21: 19-26 Year: 2012 Novel treatment for pulmonary vascular disease: lessons from pathophysiology Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 Inhibition of the Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling Year: 2006 Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression? Source: Eur Respir J , 49 (2) 1602524; DOI: 10.1183/13993003.02524-2016 Year: 2017 Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression? Source: Eur Respir J , 49 (2) 1602345; DOI: 10.1183/13993003.02345-2016 Year: 2017 Roundabout (Robo) receptors on pulmonary artery endothelial cells: Implications for pulmonary arterial hypertension Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature Source: Eur Respir J 2014; 44: 1275-1288 Year: 2014 Contribution of angiopoietin/Tie2 pathway to pulmonary artery smooth muscle hyperplasia in idiopathic pulmonary hypertension Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 Role of JAK2/STAT3 pathway in vascular function of pulmonary fibrosis patients Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 The role of vascular endothelial growth factor D in diagnosis of polycystic lung diseases Source: Annual Congress 2013 –Clinical management of orphan lung diseases Year: 2013 Role of vascular endotelial growth factor polymorphisms in interstitial lung disease Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 The Role of Inflammation in promoting pulmonary hypertension in idiopatchi and connective tissue disease-associated PAH Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008 Stabilised ferroportin activity affects pulmonary vascular cells responses: implications for pulmonary hypertension Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 Dual mechanism of platelet-derived growth factor (PDGF)-receptor: Contribution of vascular response to the pathogenesis of pulmonary hypertension (PH) Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Vascular density in fibrotic ILD: too much or not enough vessels? Source: Annual Congress 2012 - Pulmonary injury and repair from alveolus to vessel walls Year: 2012 PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 MicroRNA-155 controls pulmonary artery fibroblast cell signalling and proliferation in a knockout mouse model: A role in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Pulmonary vein stenosis mimicking interstitial lung disease Source: International Congress 2019 – CCC Pulmonary vascular diseases Year: 2019